Audrey Hennequin

Tumor infiltration by Tbet+ effector T cells and CD20+ B cells is associated with survival in gastric cancer patients

Audrey Hennequin, Valentin Dérangère, Romain Boidot et al. · OncoImmunology · 2015 · 224 citations · Full text

Medicine, Oncology, Pathology +14

Monitoring HSP70 exosomes in cancer patients’ follow up: a clinical prospective pilot study

Gaëtan Chanteloup, Marine Cordonnier, Nicolás Isambert et al. · Journal of Extracellular Vesicles · 2020 · 108 citations · Full text

Medicine, Molecular Biology, Oncology +16

Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study

Nicolás Isambert, Alice Hervieu, Cédric Rébé et al. · OncoImmunology · 2018 · 89 citations · Full text

Medicine, Oncology, Pharmacology +9

Primary analysis from DS8201-A-U105: A phase 1b, two-part, open-label study of trastuzumab deruxtecan (T-DXd) with nivolumab (nivo) in patients (pts) with HER2-expressing urothelial carcinoma (UC).

Matt D. Galsky, Gianluca Del Conte, Silvia Foti et al. · Journal of Clinical Oncology · 2022 · 85 citations

Medicine, Oncology, Pharmacology +17

Second-line endocrine therapy (ET) with or without palbociclib (P) maintenance in patients (pts) with hormone receptor-positive (HR[+])/human epidermal growth factor receptor 2-negative (HER2[-]) advanced breast cancer (ABC): PALMIRA trial.

Antonio Llombart‐Cussac, Catherine Harper‐Wynne, Antonia Perelló et al. · Journal of Clinical Oncology · 2023 · 72 citations

Medicine, Oncology, Pharmacology +17